Skip to Content

Advaxis Inc

Rating as of

Company Profile

Business Description

Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer.

Contact
305 College Road East
Princeton, NJ, 8540
T +1 609 452-9813
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Jan 31, 2020
Fiscal Year End Oct 31, 2020
Stock Type Speculative Growth
Employees 35